Background: The length of the chromosome ends, telomeres, is widely accepted as a biomarker of aging. However, the dynamic of the relationship between telomere length and hematopoietic parameters in the normal aging process, which is of particular interest with respect to age-related anemia, is not well understood. Objective: We have analyzed the relationship between relative leukocyte telomere length (rLTL) and several hematological parameters in the older group of the Berlin Aging Study II (BASE-II) participants. This paper also compares rLTL between both BASE-II age groups (22-37 and 60-83 years). Methods: Genomic DNA was extracted from peripheral blood leukocytes of BASE-II participants and used to determine rLTL by a quantitative PCR protocol. Standard methods were used to determine blood parameters, and the WHO criteria were used to identify anemic participants. Results: Telomere length data were available for 444 younger participants (28.4 ± 3.1 years old; 52% women) and 1,460 older participants (68.2 ± 3.7 years old; 49.4% women). rLTL was significantly shorter in BASE-II participants of the older group (p = 3.7 × 10-12) and in women (p = 4.2 × 10-31). rLTL of older men exhibited a statistically significant, positive partial correlation with mean corpuscular hemoglobin (MCH; p = 0.012) and MCH concentration (p = 0.002). While these correlations were only observed in men, the rLTL of older women was negatively correlated with the number of thrombocytes (p = 0.015) in the same type of analysis. Among all older participants, 6% met the criteria to be categorized as ‘anemic'; however, there was no association between anemia and rLTL. Conclusion: In the present study, we have detected isolated correlations between rLTL and hematological parameters; however, in all cases, rLTL explained only a small part of the variation of the analyzed parameters. In disagreement with some other studies showing similar data, we interpret the association between rLTL and some of the hematological parameters studied here to be at most marginal. This applies also to the role of rLTL in anemia, at least in the age group investigated here. Since BASE-II is yet another large cohort in which women have on average shorter telomeres than men, this finding will be addressed in the discussion with respect to the ongoing debate on gender differences in telomere length.

1.
Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:585-621.
2.
Olovnikov AM: A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973;41:181-190.
3.
Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 1985;43:405-413.
4.
Collins K: The biogenesis and regulation of telomerase holoenzymes. Nat Rev Mol Cell Biol 2006;7:484-494.
5.
Bekaert S, De Meyer T, Van Oostveldt P: Telomere attrition as ageing biomarker. Anticancer Res 2005;25:3011-3021.
6.
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G: The hallmarks of aging. Cell 2013;153:1194-1217.
7.
Ding H, Chen C, Shaffer JR, Liu L, Xu Y, Wang X, Hui R, Wang DW: Telomere length and risk of stroke in Chinese. Stroke 2012;43:658-663.
8.
Weischer M, Bojesen SE, Cawthon RM, Freiberg JJ, Tybjaerg-Hansen A, Nordestgaard BG: Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler Thromb Vasc Biol 2012;32:822-829.
9.
Shen Q, Zhao X, Yu L, Zhang Z, Zhou D, Kan M, Zhang D, Cao L, Xing Q, Yang Y, Xu H, He L, Liu Y: Association of leukocyte telomere length with type 2 diabetes in mainland Chinese populations. J Clin Endocrinol Metab 2012;97:1371-1374.
10.
Zee RY, Castonguay AJ, Barton NS, Germer S, Martin M: Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a case-control study. Transl Res 2010;155:166-169.
11.
Rode L, Bojesen SE, Weischer M, Vestbo J, Nordestgaard BG: Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals. Thorax 2013;68:429-435.
12.
Bojesen SE: Telomeres and human health. J Int Med 2013;274:399-413.
13.
Kirwan M, Dokal I: Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta 2009;1792:371-379.
14.
De Meyer T, De Buyzere ML, Langlois M, Rietzschel ER, Cassiman P, De Bacquer D, Van Oostveldt P, De Backer GG, Gillebert TC, Van Criekinge W, Bekaert S; Asklepios Study Investigators: Lower red blood cell counts in middle-aged subjects with shorter peripheral blood leukocyte telomere length. Aging Cell 2008;7:700-705.
15.
Mollica L, Fleury I, Belisle C, Provost S, Roy DC, Busque L: No association between telomere length and blood cell counts in elderly individuals. J Gerontol A Biol Sci Med Sci 2009;64:965-967.
16.
Kozlitina J, Garcia CK: Red blood cell size is inversely associated with leukocyte telomere length in a large multi-ethnic population. PLoS One 2012;7:e51046.
17.
Den Elzen WP, Martin-Ruiz C, von Zglinicki T, Westendorp RG, Kirkwood TB, Gussekloo J: Telomere length and anaemia in old age: results from the Newcastle 85-plus Study and the Leiden 85-plus Study. Age Ageing 2011;40:494-500.
18.
Bertram L, Bockenhoff A, Demuth I, Duzel S, Eckardt R, Li SC, Lindenberger U, Pawelec G, Siedler T, Wagner GG, Steinhagen-Thiessen E: Cohort profile: The Berlin Aging Study II (BASE-II). Int J Epidemiol 2014;43:703-712.
19.
Cawthon RM: Telomere measurement by quantitative PCR. Nucl Acids Res 2002;30:e47.
20.
Callicott RJ, Womack JE: Real-time PCR assay for measurement of mouse telomeres. Comp Med 2006;56:17-22.
21.
Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 2001;29:e45.
22.
Patwardhan VN: Nutritional anemias - who research program. Early developments and progress report of collaborative studies. Am J Clin Nutr 1966;19:63-71.
23.
Thomas C, Thomas L: Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002;48:1066-1076.
24.
Eisenstaedt R, Penninx BW, Woodman RC: Anemia in the elderly: current understanding and emerging concepts. Blood Rev 2006;20:213-226.
25.
Gutmajster E, Witecka J, Wyskida M, Koscinska-Marczewska J, Szwed M, Owczarz M, Mossakowska M, Milewicz A, Puzianowska-Kuznicka M, Zejda J, Wiecek A, Chudek J, Sieron AL: Telomere length in elderly Caucasians weakly correlates with blood cell counts. Sci World J 2013;2013:153608.
26.
Lesourd B, Decarli B, Dirren H: Longitudinal changes in iron and protein status of elderly Europeans. SENECA Investigators. Eur J Clin Nutr 1996;50(suppl 2):S16-S24.
27.
Skjelbakken T, Langbakk B, Dahl IM, Lochen ML; Tromsø Study: Haemoglobin and anaemia in a gender perspective: The Trømso Study. Eur J Haematol 2005;74:381-388.
28.
Gardner M, Bann D, Wiley L, Cooper R, et al: Gender and telomere length: systematic review and meta-analysis. Exp Gerontol 2014;51:15-27.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.